Literature DB >> 10446990

Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product.

S Numata1, P P Claudio, C Dean, A Giordano, C M Croce.   

Abstract

We have cloned a gene, BDP, encoding a protein with homology to the retinoblastoma-binding proteins Rbp1 and Rbp2. It also has homology to DNA-binding proteins such as Bright, a B-cell-specific trans-activator, and the Drosophila melanogaster dead ringer gene product. Like MyoD, Bdp binds to the COOH-terminal region of pRb through its conserved region and to hypophosphorylated pRb. It also binds to the MAR of the immunoglobulin heavy-chain locus. Thus Bdp may contribute to the transcriptional regulation of genes involved in differentiation and tissue-specific expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.

Authors:  Carol F Webb; James Bryant; Melissa Popowski; Laura Allred; Dongkoon Kim; June Harriss; Christian Schmidt; Cathrine A Miner; Kira Rose; Hwei-Ling Cheng; Courtney Griffin; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

2.  Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.

Authors:  Josephine A Tidwell; Christian Schmidt; Phillip Heaton; Van Wilson; Philip W Tucker
Journal:  Mol Immunol       Date:  2011-09-28       Impact factor: 4.407

3.  ARID3B expression in primary breast cancers and breast cancer-derived cell lines.

Authors:  Ayse Selcen Oguz Erdogan; Nihan Ozdemirler; Merve Oyken; Murat Alper; Ayse Elif Erson-Bensan
Journal:  Cell Oncol (Dordr)       Date:  2014-08-14       Impact factor: 6.730

4.  A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.

Authors:  Dongkyoon Kim; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn.

Authors:  K Kobayashi; L M Jakt; S-I Nishikawa
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

Review 6.  The transcription factor, Bright, and immunoglobulin heavy chain expression.

Authors:  C F Webb
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

7.  Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer.

Authors:  Danjuan Lin; Gregory C Ippolito; Rui-Ting Zong; James Bryant; Janet Koslovsky; Philip Tucker
Journal:  Mol Cancer       Date:  2007-03-26       Impact factor: 27.401

8.  DNA-binding properties of ARID family proteins.

Authors:  Antonia Patsialou; Deborah Wilsker; Elizabeth Moran
Journal:  Nucleic Acids Res       Date:  2005-01-07       Impact factor: 16.971

9.  ARID3B Directly Regulates Ovarian Cancer Promoting Genes.

Authors:  Alexander Bobbs; Katrina Gellerman; William Morgan Hallas; Stancy Joseph; Chao Yang; Jeffrey Kurkewich; Karen D Cowden Dahl
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

10.  ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.

Authors:  Stancy Joseph; Victoria E Deneke; Karen D Cowden Dahl
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.